ligelizumab inn development code humanized monoclonal antibody designed treatment severe asthma chronic spontaneous antiige binds ighe acts drug developed novartis pharma ag research funded novartis concluded ligelizumab effective treating chronic spontaneous urticaria omalizumab immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding httpsenwikipediaorgwikiligelizumab